Aqr Capital Management LLC Insmed Inc Transaction History

Aqr Capital Management LLC

$75.6 Billion
Q4 2024

A detailed history of Aqr Capital Management LLC transactions in Insmed Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 64,171 shares of INSM stock, worth $5.07 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

64,171

Previous 62,880 2.05%

Holding current value

$5.07 Million

Previous $4.59 Million 3.49%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$66.29 - $76.63 $85,580 - $98,929	1,291 Added 2.05%	64,171 $4.43 Million
Q3 2024 Nov 14, 2024	BUY	$62.0 - $79.01 $145,886 - $185,910	2,353 Added 3.89%	62,880 $4.59 Million
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $497,552 - $1.58 Million	22,616 Added 59.66%	60,527 $4.06 Million
Q1 2024 May 15, 2024	BUY	$25.72 - $29.94 $38,219 - $44,490	1,486 Added 4.08%	37,911 $1.03 Million
Q4 2023 Feb 14, 2024	BUY	$23.42 - $31.74 $104,312 - $141,369	4,454 Added 13.93%	36,425 $1.13 Million
Q3 2023 Nov 14, 2023	SELL	$19.86 - $26.93 $30,643 - $41,552	-1,543 Reduced 4.6%	31,971 $807,000
Q2 2023 Aug 14, 2023	SELL	$16.44 - $21.1 $8,746 - $11,225	-532 Reduced 1.56%	33,514 $707,000
Q1 2023 May 15, 2023	SELL	$16.26 - $21.73 $9,398 - $12,559	-578 Reduced 1.67%	34,046 $580,000
Q4 2022 Feb 14, 2023	BUY	$16.98 - $23.15 $114,207 - $155,706	6,726 Added 24.11%	34,624 $691,000
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $396 - $535	19 Added 0.07%	27,898 $601,000
Q2 2022 Aug 15, 2022	SELL	$17.07 - $25.71 $11,505 - $17,328	-674 Reduced 2.36%	27,879 $550,000
Q2 2021 Aug 16, 2021	SELL	$24.17 - $36.01 $501,696 - $747,459	-20,757 Reduced 42.09%	28,553 $813,000
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $317,141 - $408,805	-10,084 Reduced 16.98%	49,310 $1.64 Million
Q3 2020 Nov 16, 2020	BUY	$26.0 - $34.5 $216,268 - $286,971	8,318 Added 16.29%	59,394 $1.91 Million
Q2 2020 Aug 17, 2020	SELL	$14.11 - $29.42 $42,682 - $88,995	-3,025 Reduced 5.59%	51,076 $1.41 Million
Q1 2020 May 15, 2020	SELL	$13.63 - $33.98 $217,725 - $542,796	-15,974 Reduced 22.8%	54,101 $867,000
Q4 2019 Feb 14, 2020	SELL	$16.12 - $24.98 $181,849 - $281,799	-11,281 Reduced 13.87%	70,075 $1.67 Million
Q3 2019 Nov 14, 2019	SELL	$15.49 - $25.78 $90,492 - $150,606	-5,842 Reduced 6.7%	81,356 $1.44 Million
Q2 2019 Aug 14, 2019	BUY	$23.0 - $32.19 $131,882 - $184,577	5,734 Added 7.04%	87,198 $2.23 Million
Q1 2019 May 14, 2019	BUY	$13.91 - $31.15 $107,705 - $241,194	7,743 Added 10.5%	81,464 $2.37 Million
Q4 2018 Feb 14, 2019	SELL	$11.6 - $18.7 $343,998 - $554,548	-29,655 Reduced 28.69%	73,721 $967,000
Q3 2018 Nov 15, 2018	BUY	$18.95 - $28.08 $82,868 - $122,793	4,373 Added 4.42%	103,376 $2.09 Million
Q1 2018 May 15, 2018	BUY	$21.69 - $32.99 $66,609 - $101,312	3,071 Added 3.2%	99,003 $2.23 Million
Q4 2017 Feb 14, 2018	BUY	$26.43 - $31.78 $416,431 - $500,725	15,756 Added 19.65%	95,932 $2.99 Million
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $930,843 - $2.5 Million	80,176	80,176 $2.5 Million

Others Institutions Holding INSM

# of Institutions

497

Shares Held

189M

Call Options Held

3.21M

Put Options Held

2.72M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.7B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Insmed Inc Transaction History